Viewing Study NCT06649006

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 5:17 PM
Ignite Modification Date: 2026-02-06 @ 12:06 AM
Study NCT ID: NCT06649006
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-20
First Post: 2024-10-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study to Investigate Intravenous Blinatumomab in Japanese Adult Participants With Newly Diagnosed Philadelphia-negative B-precursor Acute Lymphoblastic Leukemia (B-ALL)
Sponsor: Amgen
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B-precursor Acute Lymphoblastic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Leukemia View
None Blincyto® View
None Blinatumomab View
None B-precursor Acute Lymphoblastic Leukemia View
None B-ALL View